ArticleFrontiers in immunology2017

Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of

Federico Nicolás Penas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.